Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, INVO FERTILITY, INC. reported revenue of $7M, up 4.3% year over year. Operating margin was -105.8% and net margin -340.9%, on a free-cash-flow margin of -103.2% with capital expenditure at 0.6% of revenue. Every figure is computed directly from IVF's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $7M | -105.8% | -340.9% |
| FY2024 | $7M | -101.0% | -141.1% |
| FY2023 | $3M | -224.0% | -266.0% |
| FY2022 | $1M | -1292.5% | -1324.8% |
| FY2021 | $4M | -125.4% | -160.0% |
How does IVF compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.